Celcuity Inc
Research Celcuity Inc (CELC) on Bullrun: market cap USD 4.50B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerCELC
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 4.50B
- Financial periodQ1 2026
- RevenueUSD 0
- Net income-USD 52.84M
- Free cash flow-USD 55.35M
Valuation Snapshot
latest market cap is USD 4.50B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 177.04M | -USD 153.53M | n/a | -3.79 | USD 165.70M | USD 137.55M | USD 100.56M |
| FY2024 | USD 0 | -USD 111.78M | -USD 83.72M | n/a | -2.83 | USD 22.52M | USD 105.09M | USD 115.62M |
| FY2023 | n/a | -USD 63.78M | -USD 53.91M | n/a | -2.69 | USD 30.66M | USD 37.57M | USD 139.77M |
| FY2022 | n/a | -USD 40.37M | -USD 36.17M | n/a | -2.64 | USD 24.57M | USD 35.76M | USD 133.77M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 4.50B | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 4.81B | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 486.20M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 367.71M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 303.56M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 196.78M | n/a | n/a | n/a |
About Celcuity Inc
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
Related stock research
Other Healthcare stocks
Adicet Bio Inc (1IJ)
Cartesian Therapeutics, Inc. (1S70)
QUOIN PHARMACEUT.ADR5000 (2EB0)
Aardvark Therapeutics Inc (AARD)
Abeona Therapeutics Inc (ABEO)
Acumen Pharmaceuticals Inc (ABOS)
Absci Corp (ABSI)
Arbutus Biopharma Corp (ABUS)
ABVC BioPharma Inc (ABVC)
Acadia Pharmaceuticals Inc (ACAD)
Adicet Bio Inc (ACET)
Achieve Life Sciences Inc (ACHV)
Frequently asked questions
What is Celcuity Inc's market cap?
Celcuity Inc's market capitalization is USD 4.50B.
What does Celcuity Inc do?
Celcuity Inc., a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.